Finance

Lists
Why is ENTA up 2,79%?
Dive Deeper
ENTA:NASDAQ
Enanta Pharmaceuticals Inc
11,41 US$
+2,79%
(+0,31) 1D
11,41 US$
0,00% (0,00)
After hours
Closed: 19 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTA...
Open
11,14 US$
High
11,76 US$
Low
11,00 US$
Mkt. cap
332,32 მლნ.
Avg. vol.
266,00 ათ.
Volume
293,41 ათ.
52-wk high
17,15 US$
52-wk low
10,20 US$
EPS
-2,41 US$
Beta
0,96
Shares outstanding
29,12 მლნ.
No. of employees
120
Open
11,14 US$
High
11,76 US$
Low
11,00 US$
Mkt. cap
332,32 მლნ.
Avg. vol.
266,00 ათ.
Volume
293,41 ათ.
52-wk high
17,15 US$
52-wk low
10,20 US$
EPS
-2,41 US$
Beta
0,96
Shares outstanding
29,12 მლნ.
No. of employees
120
News stories
From web sources and news partners
About Enanta Pharmaceuticals Inc
CEO-
Employees120
Founded1995
HeadquartersWatertown, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Websiteenanta.com
Analyst ratings
Based on 1 analyst giving stock ratings to ENTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ENTA in the last 3 months
Highest
Current 11,41 US$
20,00 US$ (+75,28%)
Average
20,00 US$ (+75,28%)
Lowest
20,00 US$ (+75,28%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
20,00 US$
+75,3%
09/23/2026
Unknown Analyst
Rodman & Renshaw
Buy
Initiated
20,00 US$
+75,3%
03/26/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
19,00 US$
+66,5%
03/03/2026
Last report
10 აგვ. 2026
Fiscal period
Q3 2026
-0,67 US$ / -0,54 US$
-25,23%miss
Revenue / Est. (USD)
14,36 მლნ. / 16,37 მლნ.
-12,28%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
15,12 მლნ.
18,62 მლნ.
17,16 მლნ.
14,36 მლნ.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23,81 მლნ.
20,86 მლნ.
19,44 მლნ.
22,13 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,70 მლნ.
9,01 მლნ.
9,57 მლნ.
9,47 მლნ.
Operating expense
33,51 მლნ.
29,87 მლნ.
29,01 მლნ.
31,60 მლნ.
Total operating expenses
33,51 მლნ.
29,87 მლნ.
29,01 მლნ.
31,60 მლნ.
Operating income
-18,39 მლნ.
-11,25 მლნ.
-11,85 მლნ.
-17,24 მლნ.
Other non operating income
39,00 ათ.
-
-
-
EBT including unusual items
-18,67 მლნ.
-11,91 მლნ.
-13,08 მლნ.
-19,46 მლნ.
EBT excluding unusual items
-19,63 მლნ.
-11,89 მლნ.
-13,08 მლნ.
-19,46 მლნ.
Income tax expense
32,00 ათ.
24,00 ათ.
7,00 ათ.
36,00 ათ.
Effective tax rate
-0,17%
-0,20%
-0,05%
-0,18%
Other operating expenses
-
-
-
-
Net income
-18,70 მლნ.
-11,94 მლნ.
-13,09 მლნ.
-19,50 მლნ.
Net profit margin
-123,64%
-64,13%
-76,29%
-135,81%
Earnings per share
-0,87
-0,42
-0,45
-0,67
Interest and investment income
1,11 მლნ.
2,44 მლნ.
2,08 მლნ.
1,90 მლნ.
Interest expense
-2,39 მლნ.
-3,08 მლნ.
-3,32 მლნ.
-4,13 მლნ.
Net interest expenses
-1,28 მლნ.
-641,00 ათ.
-1,23 მლნ.
-2,23 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-17,10 მლნ.
-10,02 მლნ.
-10,64 მლნ.
-16,05 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები